Corrigendum to ‘Tumor cavitation at durvalumab initiation predicts poor survival in stage III NSCLC after concurrent chemoradiotherapy: A single-center retrospective cohort study’ [Respir Investig 64/5 (2026) 101503]

Respiratory Investigation · Elsevier

Аннотация

Publication date: Available online 12 October 2026 Source: Respiratory Investigation Author(s): Hiroaki Ota, Shota Sogabe, Yosuke Murakami, Kazuki Uchida, Takafumi Kawabata, Yuri Hiramatsu, Mitsukuni Sakabe, Katsuya Cho, Ryuta Yamamoto, Ryunosuke Ooi, Takeya Sugimoto, Kohei Yoshimine, Saori Nishizawa, Hiromi Ide, Minako Hanaka, Kazunori Tobino

Читать у издателя →

Похожие статьи